Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Sprowl

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2014
Uptake carriers and oncology drug safetyJason A Sprowl, Alex Sparreboom
Clinical Pharmacology and Therapeutics|July 21, 2018
Strategies to Reduce Solute Carrier-Mediated ToxicityShuiying Hu, Jason A Sprowl
Drug Metabolism and Pharmacokinetics|September 19, 2012
Polymorphic transporters and platinum pharmacodynamicsJason A Sprowl, Rachel A Ness, Alex Sparreboom
Molecular Pharmacology|July 31, 2021
Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing LossKyle Z Pasquariello, Jason M Dey, Jason A Sprowl
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 31, 2012
Contribution of tumoral and host solute carriers to clinical drug responseJason A Sprowl, Torben S Mikkelsen, Hugh Giovinazzo, et al.
Pharmaceutics|April 27, 2024
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?Kshitee Kharve, Andrew S Engley, Mary F Paine, et al.
BMC Cancer|September 4, 2012
Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localizationAllan D Heibein, Baoqing Guo, Jason A Sprowl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 4, 2025
Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activityElizabeth R Hayden, Vivian Xu, Lisa Krotz, et al.
Molecular Cancer Therapeutics|June 13, 2013
Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeuticsCynthia S Lancaster, Jason A Sprowl, Aisha L Walker, et al.
Cell Biology International|May 22, 2007
Changes in expression of cell wall turnover genes accompany inhibition of chromosome segregation by bovine protein kinase C alpha expression in Saccharomyces cerevisiaeJason A Sprowl, David J Villeneuve, Baoqing Guo, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2014
Uptake carriers and oncology drug safetyJason A Sprowl, Alex Sparreboom
Clinical Pharmacology and Therapeutics|July 21, 2018
Strategies to Reduce Solute Carrier-Mediated ToxicityShuiying Hu, Jason A Sprowl
Drug Metabolism and Pharmacokinetics|September 19, 2012
Polymorphic transporters and platinum pharmacodynamicsJason A Sprowl, Rachel A Ness, Alex Sparreboom
Molecular Pharmacology|July 31, 2021
Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing LossKyle Z Pasquariello, Jason M Dey, Jason A Sprowl
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 31, 2012
Contribution of tumoral and host solute carriers to clinical drug responseJason A Sprowl, Torben S Mikkelsen, Hugh Giovinazzo, et al.
Pharmaceutics|April 27, 2024
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?Kshitee Kharve, Andrew S Engley, Mary F Paine, et al.
BMC Cancer|September 4, 2012
Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localizationAllan D Heibein, Baoqing Guo, Jason A Sprowl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 4, 2025
Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activityElizabeth R Hayden, Vivian Xu, Lisa Krotz, et al.
Molecular Cancer Therapeutics|June 13, 2013
Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeuticsCynthia S Lancaster, Jason A Sprowl, Aisha L Walker, et al.
Cell Biology International|May 22, 2007
Changes in expression of cell wall turnover genes accompany inhibition of chromosome segregation by bovine protein kinase C alpha expression in Saccharomyces cerevisiaeJason A Sprowl, David J Villeneuve, Baoqing Guo, et al.
Pageof 3